Latest AIDS Vaccine 200 Stories
All-volunteer organization that produces annual AV200 cycling fundraiser adds board members and continues planning its 13th event, slated for May 16-17, 2015 Atlanta,
ATLANTA, April 27, 2011 /PRNewswire/ -- GeoVax Labs, Inc.
ATLANTA, April 7, 2011 /PRNewswire/ -- Harriet Robinson, Ph.D., Chief Scientific Officer at GeoVax Labs, Inc.
ATLANTA, Jan. 6 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc.
ATLANTA, Nov. 6 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc.
Atlanta to Serve as Stage for Premier Discussion on HIV Vaccine Development NEW YORK, Sept.
WASHINGTON, May 18 /PRNewswire-USNewswire/ -- Every nine and a half minutes someone in the United States is infected with HIV. The Centers for Disease Control and Prevention (CDC) estimates that approximately 56,300 individuals became infected with HIV in 2006 alone.
Human testing of an AIDS vaccine is moving into its second phase in China, researchers said Saturday. Chinese scientists said they intend to enroll 30 more volunteers for the next round of tests, Xinhua reported.
ATLANTA, March 12 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc.
- A pivoted catch designed to fall into a notch on a ratchet wheel so as to allow movement in only one direction (e.g. on a windlass or in a clock mechanism), or alternatively to move the wheel in one direction.